Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Eric J Jaehnig
Affiliation
Baylor College of Medicine
ORCID
Career Start Year
2003
Papers
18
H Index
12
Expertise
CM4AI Collaborator
Trey Ideker (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37993103
IDPpub: Illuminating the Dark Phosphoproteome Through PubMed Mining.
Mol Cell Proteomics
2024
37993103
IDPpub: Illuminating the Dark Phosphoproteome Through PubMed Mining.
Mol Cell Proteomics
2024
36711982
Deep learning prediction boosts phosphoproteomics-based discoveries through improved phosphopeptide identification.
bioRxiv
2023
37587913
Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins.
Cancer Res Commun
2023
36711982
Deep learning prediction boosts phosphoproteomics-based discoveries through improved phosphopeptide identification.
bioRxiv
2023
37137501
The Breast Cancer Proteome and Precision Oncology.
Cold Spring Harb Perspect Med
2023
37587913
Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins.
Cancer Res Commun
2023
37137501
The Breast Cancer Proteome and Precision Oncology.
Cold Spring Harb Perspect Med
2023
36271853
OmicsEV: a tool for comprehensive quality evaluation of omics data tables.
Bioinformatics
2022
36001024
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.
Cancer Discov
2022
36271853
OmicsEV: a tool for comprehensive quality evaluation of omics data tables.
Bioinformatics
2022
36001024
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.
Cancer Discov
2022
33417831
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Cancer Cell
2021
33417831
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Cancer Cell
2021
31114916
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.
Nucleic Acids Res
2019
31114916
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.
Nucleic Acids Res
2019
28570265
Identification and characterization of a supraclavicular brown adipose tissue in mice.
JCI Insight
2017
28570265
Identification and characterization of a supraclavicular brown adipose tissue in mice.
JCI Insight
2017
26811383
MEF2C regulates outflow tract alignment and transcriptional control of Tdgf1.
Development
2016
26811383
MEF2C regulates outflow tract alignment and transcriptional control of Tdgf1.
Development
2016
25848030
Cell-autonomous activation of Hedgehog signaling inhibits brown adipose tissue development.
Proc Natl Acad Sci U S A
2015
25848030
Cell-autonomous activation of Hedgehog signaling inhibits brown adipose tissue development.
Proc Natl Acad Sci U S A
2015
26437225
Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition.
Oncotarget
2015
26437225
Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition.
Oncotarget
2015
23810556
Checkpoint kinases regulate a global network of transcription factors in response to DNA damage.
Cell Rep
2013
23810556
Checkpoint kinases regulate a global network of transcription factors in response to DNA damage.
Cell Rep
2013
21127252
Rewiring of genetic networks in response to DNA damage.
Science
2010
21127252
Rewiring of genetic networks in response to DNA damage.
Science
2010
19477695
Perspectives on the DNA damage and replication checkpoint responses in Saccharomyces cerevisiae.
DNA Repair (Amst)
2009
19477695
Perspectives on the DNA damage and replication checkpoint responses in Saccharomyces cerevisiae.
DNA Repair (Amst)
2009
17030629
Increased susceptibility to isoproterenol-induced cardiac hypertrophy and impaired weight gain in mice lacking the histidine-rich calcium-binding protein.
Mol Cell Biol
2006
17030629
Increased susceptibility to isoproterenol-induced cardiac hypertrophy and impaired weight gain in mice lacking the histidine-rich calcium-binding protein.
Mol Cell Biol
2006
15082771
HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo.
Mol Cell Biol
2004
15082771
HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo.
Mol Cell Biol
2004
12766070
Multiple determinants contribute to the virulence of HSV ocular and CNS infection and identification of serine 34 of the US1 gene as an ocular disease determinant.
Invest Ophthalmol Vis Sci
2003
12766070
Multiple determinants contribute to the virulence of HSV ocular and CNS infection and identification of serine 34 of the US1 gene as an ocular disease determinant.
Invest Ophthalmol Vis Sci
2003
1 - 36 of 36
Column Actions
Search
Recommended Authors
Gian Luca Negri
British Columbia Cancer Research Institute
Career Start Year
2013
Number of shared co-authors
3
Tuo Zhang
Weill Cornell Medical College.
Career Start Year
2013
Number of shared co-authors
0
Min Gao
College of Horticulture, China Agricultural University
Career Start Year
2012
Number of shared co-authors
3
Eric Paquet
University of Laval
Career Start Year
2007
Number of shared co-authors
1
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year
2004
Number of shared co-authors
0
Michael B Major
Washington University in St. Louis
Career Start Year
2004
Number of shared co-authors
0
Christopher C Ebmeier
University of Colorado
Career Start Year
2004
Number of shared co-authors
0
Chenwei Wang
Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University
Career Start Year
2003
Number of shared co-authors
2
Syed Haider
Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
1
Franco J Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year
2002
Number of shared co-authors
2
Ruth Isserlin
University of Toronto
Career Start Year
2002
Number of shared co-authors
2
Christina K Yung
Ontario Institute for Cancer Research
Career Start Year
2000
Number of shared co-authors
2
Jayantha Gunaratne
Institute of Molecular and Cell Biology
Career Start Year
2000
Number of shared co-authors
3
Chenwei Lin
Clinical Research Division, Fred Hutchinson Cancer Center
Career Start Year
2000
Number of shared co-authors
11
Celine Lefebvre
The Scripps Research Institute
Career Start Year
1999
Number of shared co-authors
1
Braden Boone
HudsonAlpha Institute for Biotechnology
Career Start Year
1999
Number of shared co-authors
2
Marcus B Smolka
Weill Institute for Cell and Molecular Biology, Cornell University
Career Start Year
1998
Number of shared co-authors
4
Aaron Aslanian
Salk Institute for Biological Studies
Career Start Year
1998
Number of shared co-authors
2
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
2
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
0
James A Wohlschlegel
David Geffen School of Medicine, University of California Los Angeles
Career Start Year
1996
Number of shared co-authors
3
Matthias Gstaiger
Institute of Molecular Systems Biology, ETH Zurich
Career Start Year
1994
Number of shared co-authors
2
Brian Raught
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1994
Number of shared co-authors
3
Andrea Califano
Columbia University
Career Start Year
1993
Number of shared co-authors
8
Steven P Gygi
Harvard Medical School
Career Start Year
1991
Number of shared co-authors
7
Frank C P Holstege
Princess Maxima Center for Pediatric Oncology
Career Start Year
1990
Number of shared co-authors
10
Mike Tyers
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Career Start Year
1986
Number of shared co-authors
2
Hediye Erdjument-Bromage
Neuroscience Institute, NYU Grossman School of Medicine
Career Start Year
1984
Number of shared co-authors
2
Stephen J Elledge
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1982
Number of shared co-authors
4
Michael Snyder
Stanford University
Career Start Year
1981
Number of shared co-authors
18
row(s) 1 - 30 of 30
Collaborators
Bing Zhang
Baylor College of Medicine
Co-authored papers
6
Jonathan T Lei
Co-authored papers
5
Meenakshi Anurag
Co-authored papers
4
Bo Wen
Co-authored papers
4
Zhiao Shi
Co-authored papers
4
Matthew J Ellis
Co-authored papers
4
Richard D Kolodner
Ludwig Institute for Cancer Research San Diego Branch
Co-authored papers
3
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers
3
Yuxing Liao
Co-authored papers
3
Brian L Black
Cardiovascular Research Institute, University of California san francisco
Co-authored papers
3
Michael A Gillette
Co-authored papers
2
Foluso O Ademuyiwa
Co-authored papers
2
Alexander B Saltzman
Co-authored papers
2
George Miles
Co-authored papers
2
Dwight Kuo
University of California
Co-authored papers
2
Karsten Krug
Co-authored papers
2
Yongchao Dou
Co-authored papers
2
Sara R Savage
Co-authored papers
2
Beom-Jun Kim
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers
2
Ana I Robles
Co-authored papers
2
Katherine Licon
University of California San Diego
Co-authored papers
2
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers
2
Tara Hiltke
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers
2
Haico van Attikum
Leiden University Medical Center
Co-authored papers
2
Shankha Satpathy
Co-authored papers
2
Mothaffar F Rimawi
Co-authored papers
2
Deepak Mani
Co-authored papers
2
Yize Li
Co-authored papers
1
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers
1
Hui Zhang
Co-authored papers
1
1 - 30